Showing results (2131-2140 of 9,904) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|June 9, 2016
Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single centerG Dufort, L Castillo, S Pisano, et al.Bone Marrow Transplantation|May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myelomaD J Green, W I Bensinger, L A Holmberg, et al.Bone Marrow Transplantation|November 25, 2014
Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCTE N Amin, G S Phillips, P Elder, et al.Bone Marrow Transplantation|July 12, 2016
Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantationJ A Gutman, K Ross, C Smith, et al.Bone Marrow Transplantation|July 5, 2016
Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective studyK E B van Veen, M C Brouwer, A van der Ende, et al.Bone Marrow Transplantation|June 14, 2016
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years)M Pohlen, C Groth, T Sauer, et al.Bone Marrow Transplantation|December 1, 1989
Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 yearsT De Witte, P Muus, B De Pauw, et al.Bone Marrow Transplantation|December 1, 1989
Allogeneic bone marrow transplantation for multiple myelomaS Tura, M Cavo, G Rosti, et al.Bone Marrow Transplantation|December 1, 1989
Graft versus host disease--clinical features and biologyA J BarrettBone Marrow Transplantation|September 1, 1989
Cytomegalovirus seroconversion in patients receiving intensive induction therapy prior to allogeneic bone marrow transplantationS M Kelsey, A C NewlandPageof 991